Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 6/20 | 0.53 |
| ▸ | KDM1A | O60341 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.50 |
| ▸ | HTR1A | P08908 | 3/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.50 |
| ▸ | DRD1 | P21728 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.50 |
| ▸ | DRD3 | P35462 | 3/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.50 |
| ▸ | PRNP | P04156 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8089788 | 0.98 | MAOA (0.56) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL17964491 | 0.80 | MAOA (0.43) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| Iodide SCHEMBL16344751 | 0.79 | MAOA (0.42) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL231247 | 0.73 | MAOA (1.00) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL29377505 | 0.73 | MAOA (1.00) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL11218770 | 0.73 | BCHE (0.53) | MAOABCHECYP2D6CYP2C19TSHR | |
| SCHEMBL9611564 | 0.72 | KDM1A (0.68) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL1718054 | 0.72 | MAOA (0.64) | MAOABCHEKDM1AADRA2ASLC6A2 | |
| SCHEMBL9724497 | 0.72 | KDM1A (0.47) | MAOABCHEKDM1ACYP2D6CHRM2 | |
| SCHEMBL15229632 | 0.71 | BCHE (0.49) | MAOABCHEKDM1ACYP2D6CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674021-B1 | Process for inhibiting metal corrosion in aquous systems | SCHILLING CHEMIE GMBH U PRODUK (DE) | 2000-12-06 | — | — | EP | claimed |
| US-20220393117-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-12-08 | — | — | US | disclosed |
| US-9670330-B2 | Method and dye mixtures for marking shape memory polymers, and shape memory polymer articles with switchable readability | BAM Bundesanstalt fuer Materialforschung und—Pruefung (DE) | 2017-06-06 | — | — | US | disclosed |
| EP-2820003-B9 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | UNIVERSITÉ CLAUDE BERNARD LYON I (FR) | 2017-05-03 | — | — | EP | disclosed |
| US-9540405-B2 | Diaminophenothiazinium derivatives for labelling biomolecules, method and substrate for labelling oligonucleotides, and oligonucleotides obtained | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2017-01-10 | — | — | US | disclosed |
| EP-2820003-B1 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | UNIVERSITÉ CLAUDE BERNARD LYON I (FR) | 2016-08-10 | — | — | EP | disclosed |
| US-20150011712-A1 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2015-01-08 | — | — | US | disclosed |
| EP-2820003-A1 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | Université Claude Bernard Lyon I (FR) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013128099-A1 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2013-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393117-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NPY1R, NPY2R, KISS1R | MAOA 3073/4885BCHE 4738/4885KDM1A 338/4885 |
| US-20150011712-A1 | DIAMINOPHENOTHIAZINIUM DERIVATIVES FOR LABELLING BIOMOLECULES, METHOD AND SUBSTRATE FOR LABELLING OLIGONUCLEOTIDES, AND OLIGONUCLEOTIDES OBTAINED | POLRMT, RNASEH1, PDXK | MAOA 551/4885BCHE 4093/4885KDM1A 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.